These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 6484897)

  • 1. Oral contraceptives and surgery: reduced antithrombin and antifactor Xa levels without postoperative venous thrombosis in low-risk patients.
    Gallus AS; Chooi CC; Konetschnik F; Goodall KT
    Thromb Res; 1984 Sep; 35(5):513-26. PubMed ID: 6484897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population-based study of risk of venous thromboembolism associated with various oral contraceptives.
    Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR
    Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen-containing oral contraceptive agents. A basis for their thrombogenicity.
    Wessler S; Gitel SN; Wan LS; Pasternack BS
    JAMA; 1976 Nov; 236(19):2179-82. PubMed ID: 989807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of oestrogen dose and progestogen type on haemostatic changes in women taking low dose oral contraceptives.
    Norris LA; Bonnar J
    Br J Obstet Gynaecol; 1996 Mar; 103(3):261-7. PubMed ID: 8630312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in haemostasis after stopping the combined contraceptive pill: implications for major surgery.
    Robinson GE; Burren T; Mackie IJ; Bounds W; Walshe K; Faint R; Guillebaud J; Machin SJ
    BMJ; 1991 Feb; 302(6771):269-71. PubMed ID: 1998792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboembolic disease developing during oral contraceptive therapy in young females with antiphospholipid antibodies.
    Girolami A; Zanon E; Zanardi S; Saracino MA; Simioni P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):497-501. PubMed ID: 8840004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombin III, heparin cofactor and antifactor Xa in relation to age, sex and pathological condition.
    Panicucci F; Sagripanti A; Conte B; Pinori E; Vispi M; Lecchini L
    Haemostasis; 1980; 9(5):297-302. PubMed ID: 7409613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood changes in sex steroid hormone users. Circulating immune complexes induced by estrogens and progestogens and their relation to vascular thrombosis.
    Beaumont V; Delplanque B; Lemort N; Beaumont JL
    Atherosclerosis; 1982 Sep; 44(3):343-53. PubMed ID: 7150397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M; Kitchens CS; Khan FY
    Am J Obstet Gynecol; 1992 Nov; 167(5):1255-61. PubMed ID: 1442974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Smoking and use of oral contraceptives: impact on thrombotic diseases.
    Lidegaard O
    Am J Obstet Gynecol; 1999 Jun; 180(6 Pt 2):S357-63. PubMed ID: 10368521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral contraception and risk of a cerebral thromboembolic attack: results of a case-control study.
    Lidegaard O
    BMJ; 1993 Apr; 306(6883):956-63. PubMed ID: 8490470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Should the pill be stopped preoperatively?
    Sue-Ling H; Hughes LE
    Br Med J (Clin Res Ed); 1988 Feb; 296(6620):447-8. PubMed ID: 3126855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antithrombin III in oral contraceptive users and during normotensive pregnancy.
    Weenink GH; Kahlé LH; Lamping RJ; ten Cate JW; Treffers PE
    Acta Obstet Gynecol Scand; 1984; 63(1):57-61. PubMed ID: 6720257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep vein thrombosis and changes in coagulation and fibrinolysis after gynaecological operations in Chinese: the effect of oral contraceptives and malignant disease.
    Tso SC; Wong V; Chan V; Chan TK; Ma HK; Todd D
    Br J Haematol; 1980 Dec; 46(4):603-12. PubMed ID: 7437338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral contraceptives, antithrombin- III activity, and postoperative deep-vein thrombosis.
    Sagar S; Stamatakis JD; Thomas DP; Kakkar VV
    Lancet; 1976 Mar; 1(7958):509-11. PubMed ID: 55783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in understanding clotting and evaluating patients with recurrent thrombosis.
    Alving BM; Comp PC
    Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 2):1184-91. PubMed ID: 1415444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased heparin cofactor II levels in women taking oral contraceptives.
    Toulon P; Bardin JM; Blumenfeld N
    Thromb Haemost; 1990 Nov; 64(3):365-8. PubMed ID: 2096488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.